These results were consistent with the previous findings on the role of ACTL6A as an oncogene in HCC and indicated that FBXW7 inhibits the stemness of tumors by suppressing the functions of ACTL6A. The gene discussed is ACTL6A; the disease is hepatocellular carcinoma.